ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,792 | -32.7% | 811 | -10.7% | 0.00% | – |
Q2 2023 | $32,379 | -98.6% | 908 | -98.4% | 0.00% | -100.0% |
Q4 2022 | $2,297,805 | -89.6% | 56,652 | -91.5% | 0.01% | -90.9% |
Q3 2022 | $22,031,000 | +58.1% | 666,600 | +68.4% | 0.09% | +49.2% |
Q2 2022 | $13,939,000 | -46.0% | 395,868 | -29.4% | 0.06% | -42.2% |
Q1 2022 | $25,805,000 | +778.6% | 561,100 | +1166.8% | 0.10% | +750.0% |
Q4 2021 | $2,937,000 | -70.7% | 44,292 | -72.4% | 0.01% | -72.7% |
Q3 2021 | $10,020,000 | +116.4% | 160,500 | +187.1% | 0.04% | +109.5% |
Q2 2021 | $4,630,000 | -91.9% | 55,900 | -95.8% | 0.02% | -92.9% |
Q3 2020 | $57,395,000 | +11.7% | 1,332,899 | +12.0% | 0.29% | -12.2% |
Q2 2020 | $51,388,000 | +30671.3% | 1,189,807 | +12979.1% | 0.34% | +33400.0% |
Q1 2019 | $167,000 | +169.4% | 9,097 | +7.0% | 0.00% | – |
Q3 2016 | $62,000 | -95.4% | 8,500 | -96.7% | 0.00% | -100.0% |
Q2 2016 | $1,362,000 | – | 256,101 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |